Repligen | RGEN - Action





Action Changement Date
Agilent USD 1.09B 30M 2026-03
Align Technology USD 214.94M 11.4M 2026-03
Bio Techne USD 201.18M 4.27M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Bruker USD 1.12B 26.9M 2026-03
Charles River Laboratories USD 359.72M 60.62M 2026-03
Danaher USD 2.61B 119M 2026-03
Dentsply International USD 659M 17M 2026-03
General Electric Aerospace USD 12.37B 499M 2026-03
Henry Schein USD 2.01B 12M 2026-03
Illumina USD 611M 47M 2026-03
Mettler Toledo International USD 404.83M 17.6M 2026-03
Myriad Genetics USD 27.9M 2.7M 2026-03
OraSure Technologies USD 30.31M 753K 2026-03
Pacific Biosciences Of California USD 51.02M 1.74M 2026-03
Pfizer USD 10.67B 13M 2026-03
Repligen USD 179.26M 8.8M 2026-03
Revvity USD 387.5M 8.01M 2026-03
Standard Biotools USD 18.59M 1.39M 2026-03
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Waters USD 1.5B 923.63M 2026-03
West Pharmaceutical Services USD 452.6M 8.7M 2026-03